Previous research has shown that PAM can specifically elevate ROS levels in androgen receptor (AR)-independent prostate cancer cells, which in turn suppresses cell migration, triggers G0/G1 phase cell cycle arrest and promotes apoptosis [29]. Here, AR is linked to prostate cancer.